GLP-1 Market
LLY $1347.11 ▼ -0.3% NVO $37.82 ▼ -2.7% PFE $27.40 ▼ -0.5% VKTX $24.77 ▼ -4.1% KLRA $11.02 ▼ -4.8% GPCR $16.13 ▼ -5.8% RHHBY $58.46 ▼ -0.9%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Ferric Bepectate

Company
AFT Pharmaceuticals, Ltd.
Mechanism
Mechanism not yet reported
Route
Injectable
Recruiting trials
1 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

1 recruiting study currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Nov 21, 2026

Find a Clinical Trial Near Me

See recruiting studies for Ferric Bepectate and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT07687784

    A Study to Test the Non-Inferiority of Ferric Bepectate IV Against Ferric Carboxymaltose in Patients With Iron Deficiency Anemia

    Not yet reported AFT Pharmaceuticals, Ltd. 1366 participants Est. completion 2028-07 24 sites Stand-alone
    Other conditions: Iron Deficiency Anemia (IDA)
    View official trial listing →
  • Completed NCT NCT03817957

    Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron Deficiency

    Not yet reported Prof. Dr. Frank Behrens 187 participants Est. completion 2024-10-21 1 site
    Other conditions: Iron Deficiency Anemia
    View official trial listing →
  • Withdrawn NCT NCT04087993

    Polyglucoferron Compared to i.v. Ferric Carboxymaltose and Oral Iron Substitution in Preoperative Treatment of Iron Deficiency Anaemia in Patients

    Not yet reported Dr. Frank Behrens Est. completion 2020-12-31 1 site
    Other conditions: Iron Deficiency Anemia
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Ferric Bepectate, Ferric Bepectate IV Injection, Feramyl

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.